secwatch.observer — SEC 8-K summary
======================================

Issuer:     YIELD10 BIOSCIENCE, INC. (—)
CIK:        0001121702
Form:       8-K
Filed at:   2023-05-19T23:59:59+00:00
Accession:  0001121702-23-000027
Event type: regulatory
Sentiment:  negative
Materiality: 0.90
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Yield10 Bioscience gets Nasdaq deficiency letter for equity of $1.143M, below $2.5M minimum
--------------------------------------------------------------------------------

- Received Nasdaq deficiency letter on May 18, 2023 for failing minimum stockholders' equity requirement.
- Stockholders' equity reported at $1,143,000 as of March 31, 2023, well below the $2.5M threshold.
- Must submit a compliance plan by July 3, 2023; Nasdaq may grant up to 180-day extension if plan accepted.
- No immediate effect on listing; company can appeal a rejected plan to Nasdaq Hearings Panel.
- Company intends to submit plan and explore options but cannot assure regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1121702/000112170223000027/0001121702-23-000027-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1121702/000112170223000027/yten-20230518.htm
  HTML page:      https://secwatch.observer/filing/0001121702-23-000027

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer